CVS Health Corp. (NYSE: CVS) Q3 2020 earnings call dated Nov. 06, 2020
Corporate Participants:
Valerie C Haertel — Senior Vice President, Investor Relations
Larry J. Merlo — President and Chief Executive Officer
Karen S. Lynch — Executive Vice President, CVS Health and President, Aetna
Eva C. Boratto — Executive Vice President and Chief Financial Officer
Alan M. Lotvin — Executive Vice President, CVS Health and President CVS Caremark
Jonathan C. Roberts — Executive Vice President and Chief Operating Officer
Analysts:
Lisa Gill — J.P. Morgan — Analyst
Eric Percher — Nephron Research LLC — Analyst
Ricky Goldwasser — Morgan Stanley — Analyst
A.J. Rice — Credit Suisse — Analyst
Charles Rhyee — Cowen and Company — Analyst
George Hill — Deutsche Bank — Analyst
Lance Wilkes — Sanford C. Bernstein — Analyst
Michael Cherny — Bank of America Merrill Lynch — Analyst
Ann Hynes — Mizuho Securities — Analyst
Steven Valiquette — Barclays — Analyst
Justin Lake — Wolfe Research — Analyst
_____
To read the full earnings call transcript, click here.
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,